Contrasting actions of celiprolol and metoprolol on cardiac performance in normal volunteers

Cardiovascular Drugs and Therapy

Volumn 11, Issue 1, 1997, Pages 57-61

  Silke, B ^a   Thompson, A ^a   Riddell, J G ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Beta blockade; Chronotropy; Comparison; Inotropy; Partial agonism

Indexed keywords

CELIPROLOL; METOPROLOL;

ADULT; AORTA FLOW; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EXERCISE; HEART FUNCTION; HEART INDEX; HEART PERFORMANCE; HEART RATE; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REST; WORKLOAD;

ADRENERGIC BETA-ANTAGONISTS; ADULT; CELIPROLOL; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY, DOPPLER; HEART RATE; HUMANS; MALE; METOPROLOL; MYOCARDIAL CONTRACTION; REFERENCE VALUES;

EID: 0030957382     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007799807554     Document Type: Article

References (31)

1. Pruss TP, Khanswala A, Wolf PS, Grebow P, Wong L. Celiprolol: A new beta adrenoceptor antagonist with novel ancillary properties. J Cardiovasc Pharmacol 1986;8(Suppl 4):S29-S32.
2. Tham TCK, Riddell JG, Shanks RG. The effect of increasing doses of celiprolol on sleeping heart rate and quality of sleep in man. Clin Pharmacol Ther 1991;49:187:PIII-54.
3. Lamon KD. Clinical safety and efficacy of celiprolol. Am Heart J 1991;121:683-687.
4. Heublein B, Modersohn D, Franz N, Panzner B. Acute haemodynamic profile of celiprolol in patients with coronary heart disease and hypertension: A double blind comparison with metoprolol. Eur Heart J 1991;12:617-623.
5. Mancia G, Grassi G, Parati G, et al. Effects of celiprolol on reflex control of the cardiovascular system in essential hypertension. J Cardiovasc Pharmacol 1986;8(Suppl 4):S67-S74.
6. McLenachan JM, Grant S, Ford I, Henderson E, Dargie HJ. Submaximal, but not maximal, exercise testing detects differences in the effects of beta-blockers during treadmill exercise: A study of celiprolol and atenolol. Am Heart J 1991; 121:691-695.
7. McDevitt DG, Brown CH, Carruthers GS, Shanks RG. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta-adrenoceptor blockade. J Clin Pharmacol 1977;21:556-566.
8. Wheeldon NM, McDevitt DG, Lipworth BJ. Evaluation of in vivo partial beta1/beta2-agonist activity: A dose-ranging study with carteolol. Br J Clin Pharmacol 1992;33:411-416.
9. Wheeldon NM, McDevitt DG, Lipworth BJ. Selectivity of antagonist and partial agonist activity of celiprolol in normal subjects. Br J Clin Pharmacol 1992;34:337-343.
10. Kolettis M, Jenkins BS, Webb-Peploe MM. Assessment of left ventricular function by indices derived from aortic flow velocity. Br Heart J 1984;38:18-31.
11. Bennett ED, Barclay SA, Davis AI, Mannering D, Mehta N. Ascending aortic blood velocity and acceleration using Doppler ultrasound in the assessment of left ventricular function. Cardiovasc Res 1984;18:632-638.
12. Clifton DG, Harrison MR, DeMaria AN. Influence of beta adrenergic blockade upon hemodynamic response to exercise assessed by Doppler echocardiography. Am Heart J 1990;120:579-584.
13. Mehta N, Boyle G, Bennet D, Gilmour S, Noble MIM, Mills CM, Pugh S. Haemodynamic response to treadmill exercise in normal volunteers: An assessment by Doppler ultrasonic measurement of ascending aortic blood velocity and acceleration. Am Heart J 1988;116:1298,1307.
14. Bojanowski LMR, Timmis AD, Najm YC, Gosling RG. Pulsed Doppler ultrasound compared with thermodilution for monitoring cardiac output responses to changing left ventricular function. Cardiovasc Res 1987;21:260-268.
15. Bedotto JB, Eichhorn EJ, Grayburn PA. Effects of left ventricular preload and afterload on ascending aortic blood velocity and acceleration in coronary artery disease. Am J Cardiol 1989;64:856-859.
16. Gardin JM. Doppler measurements of aortic blood flow velocity and acceleration: Load-independent indexes of left ventricular performance? Am J Cardiol 1989;64:935-936.
17. Harrison MR, Clifton GD, Berk MR, DeMaria AN. Effect of systolic blood pressure and afterload on Doppler echocardiographic measurements of systolic function in normal subjects. Am J Cardiol 1989;64:905-908.
18. Silke B, Thompson A, Leitch A, Riddell JG. A placebo controlled comparison of the effects of metoprolol and celiprolol on echo-Doppler measurements of cardiovascular function in normal volunteers. Br J Clin Pharmacol 1995; 40:37-42.
19. Wheeldon NM, McDevitt DG, Lipworth BJ. Selectivity of antagonist and partial agonist effects of celiprolol in normal subjects. Br J Clin Pharmac 34:337-343.
20. Harron DWG, Balnave K, Kinney CD, Wilson R, Russell CJ, Shanks RG. Effects on exercise tachycardia during forty-eight hours of a series of doses of atenolol, sotalol, and metoprolol. J Clin Pharmacol 1981;29:259-302.
21. Jassal V, Harris CM, Silke B. Reproducibility of a new continuous echo-Doppler method (Exerdop) in man. Br J Clin Pharmacol 1993;35:87P.
22. Ramsey M. Non-invasive automatic determination of mean arterial blood pressure. Med Biol Eng Comput 1979;17:11-18.
23. Button P, Dye J, Prys-Roberts C. An assessment of the Dinamap 845. Anaesthesia 1984;39:261-267.
24. Winer BJ. Statistical Principles in Experimental Design, 2nd. ed. New York: McGraw-Hill, 1971.
25. Altman DG, Gardner MJ. Calculating confidence intervals for regression and correlation. Br Med J 1988;296:1238-1242.
26. Zar JH. Multiple regression and correlation. In: Biostatistical Analysis, 2nd ed. Englewood Cliffs, NJ: Prentice-Hall, 1984.
27. Wheeldon NM, McDevitt DG, Lipworth BJ. Evaluation of the selectivity of antagonist and partial agonist effects of celiprolol in normal subjects. Br J Clin Pharmacol 1992;33: 528P.
28. Harry JD, Millson DS, Morton PB. Use of Doppler echocardiography to determine the cardiac effects of dobutamine in volunteers. J Pharm Med 1988;3:173-183.
29. de Mey C, Belz GG, Nixdorf U, Butzer R, Schroeter V, Meyer J, Erbel R. Relative sensitivity of four non-invasive methods in assessing systolic cardiovascular effects of isoproterenol in healthy volunteers. Clin Pharmacol Ther 1992; 52:609-619.
30. Harrison MR, Clifton GD, DeMaria AN. Hemodynamics effects of calcium channel and beta-receptor antagonists: Evaluation by Doppler echocardiography. Am Heart J 1990; 121:126-133.
31. Clifton DG, Pennel AT, Harrison MR. Pharmacodynamics of propranolol on left ventricular function: Assessment by Doppler echocardiography. Clin Pharmacol Ther 1990;48: 431-438.